Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine
Language English Country Germany Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22944669
DOI
10.1515/hsz-2011-0279
PII: /j/bchm.2012.393.issue-7/hsz-2011-0279/hsz-2011-0279.xml
Knihovny.cz E-resources
- MeSH
- Adenine analogs & derivatives pharmacology MeSH
- Autophagy drug effects MeSH
- Benzophenanthridines antagonists & inhibitors pharmacology MeSH
- Imidazoles pharmacology MeSH
- Indoles pharmacology MeSH
- Caspases metabolism MeSH
- Humans MeSH
- Melanoma pathology MeSH
- Cell Line, Tumor MeSH
- Necrosis chemically induced MeSH
- Microtubule-Associated Proteins metabolism MeSH
- Antineoplastic Agents antagonists & inhibitors pharmacology MeSH
- Proto-Oncogene Proteins c-bcl-2 metabolism MeSH
- Gene Expression Regulation, Neoplastic drug effects MeSH
- Cell Survival drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- 3-methyladenine MeSH Browser
- Adenine MeSH
- Benzophenanthridines MeSH
- Imidazoles MeSH
- Indoles MeSH
- Caspases MeSH
- MAP1LC3A protein, human MeSH Browser
- necrostatin-1 MeSH Browser
- Microtubule-Associated Proteins MeSH
- Antineoplastic Agents MeSH
- Proto-Oncogene Proteins c-bcl-2 MeSH
- sanguilutine MeSH Browser
We show that the plant quaternary benzo[c]phenanthridine alkaloid sanguilutine (SL) is a strong inducer of caspase-independent non-apoptotic death in human melanoma cells. Necrostatin-1, a specific inhibitor of necroptosis, completely reversed the cytotoxic effect of SL, suggesting that necroptosis was a predominant type of cell death induced by SL in these cells. In addition, we showed that SL can trigger an autophagic response, as confirmed by GFP-LC3 puncta formation and LC3-II accumulation. Interestingly, we observed a significant decrease in the viability of melanoma cells treated with combination of autophagy inhibitors (3-methyladenine, bafilomycin-A1 and LY294002) and SL. Our results further indicated that autophagy may serve as a pro-survival mechanism, delaying the induction of necroptosis in melanoma cells. The ability of SL to induce caspase-independent non-apoptotic cell death (necroptosis) suggests its possible therapeutic potential in the treatment of apoptosis-resistant melanoma tumours. Furthermore, SL might serve as a useful tool for studying the mechanisms of necroptosis and autophagy induction and the interplay between these two processes.
References provided by Crossref.org
Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis